SWU-29544-60035
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 191 / PA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
-
2021-01-07
Survey response — day 14, dose 1MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Call successfulParticipant prefers to complete VAERS report online
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-24
- 2021-04-13
- 2021-07-16
- 2022-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 1 — day 14, dose 1
Symptoms: Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release